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Background: The majority of curative health care is organized in hospitals. As in most other countries, the current
94 hospital locations in the Netherlands offer almost all treatments, ranging from rather basic to very complex care.
Recent studies show that concentration of care can lead to substantial quality improvements for complex
conditions and that dispersion of care for chronic conditions may increase quality of care. In previous studies on
allocation of hospital infrastructure, the allocation is usually only based on accessibility and/or efficiency of hospital
care. In this paper, we explore the possibilities to include a quality function in the objective function, to give global
directions to how the ‘optimal’ hospital infrastructure would be in the Dutch context.
Methods: To create optimal societal value we have used a mathematical mixed integer programming (MIP) model
that balances quality, efficiency and accessibility of care for 30 ICD-9 diagnosis groups. Typical aspects that are
taken into account are the volume-outcome relationship, the maximum accepted travel times for diagnosis groups
that may need emergency treatment and the minimum use of facilities.
Results: The optimal number of hospital locations per diagnosis group varies from 12-14 locations for diagnosis
groups which have a strong volume-outcome relationship, such as neoplasms, to 150 locations for chronic
diagnosis groups such as diabetes and chronic obstructive pulmonary disease (COPD).
Conclusions: In conclusion, our study shows a new approach for allocating hospital infrastructure over a country or
certain region that includes quality of care in relation to volume per provider that can be used in various countries
or regions. In addition, our model shows that within the Dutch context chronic care may be too concentrated and
complex and/or acute care may be too dispersed. Our approach can relatively easily be adopted towards other
countries or regions and is very suitable to perform a ‘what-if’ analysis.Background
In the Netherlands, just as in most other countries, the
majority of curative health care is organized in hospitals.
Currently, there are 94 hospital locations in the
Netherlands, almost all of them offering the whole range
of treatments, varying from placing ear tubes to cancer
treatment and long-term support of patients with COPD.
Recent studies show that quality of care can be im-
proved by concentration of care [1,2]. Within the concept
of concentration, hospitals and physicians focus on the
treatment of a selection of specific conditions, treating a* Correspondence: Ikkersheim.david@kpmgplexus.nl
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distribution, and reproduction in any mediumsubstantial volume of patients annually. Thereby they
achieve superior outcomes in terms of quality of care
[1,2]. In the literature this so called ‘volume-outcome’ as-
sociation is widely established; hospitals that treat a larger
volume of patients annually achieve better outcomes for
conditions ranging from AIDS to cholecystectomies [3].
Moreover, increased hospital specialization - meaning a
hospital that only treats certain diagnosis such as cancer
or cardiovascular diseases - is associated with improved
patient outcomes after adjusting for hospital procedural
volume [4,5].
Concentration and specialization may also increase the
efficiency of hospitals. One could expect efficiency gains
due to a higher quality of care as costly complications
may be avoided in centers that have superior expertisetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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dition(s) can lead to additional cost reductions, i.e. by
better procurement rates and higher turnover rates of
tools and capacity usage [7,8]. On the other hand a de-
crease in the number of providers may result in a lower
level of competition possibly leading to higher prices of
care [9].
In contrast to the gain in quality of care and efficiency,
concentration of care may lead to decreased accessibility
of care as the distance to the nearest hospital location
may increase. Therefore gains in quality of concentration
of care should outweigh the heightened travel costs for
patients. Studies show that a significant part of patients
are willing to travel distances for higher quality of care
[10,11], a better patient experience [12] or shorter
waiting times [13,14]. Nonetheless, studies also show
that patient preferences differ and that some patients
(up to 40%) are preferring hospital care closely to their
home rather than a short waiting time further away,
partly caused by previous satisfactory experiences in the
nearest located hospital [13].
Considering that more complex conditions have a
more profound volume-outcome association and that for
other, mostly chronic diseases, care should be provided
as close to home as possible. Therefore, the ‘ideal’ hos-
pital landscape would accommodate the quality versus
accessibility trade off with a different number of pro-
viders per (group of) condition(s). In addition, to ensure
an efficient delivery of care these providers should be
large enough to operate efficiently.
To create optimal society value in our health care sys-
tem, one should therefore optimize three dimensions:
quality, efficiency and accessibility of care [15]. In previ-
ous studies on allocation hospital infrastructure, the allo-
cation is usually based on only one or two of these
dimensions: accessibility and/or efficiency of hospital
care [16-18]. In this paper, we explore the possibilities to
include a quality function in the objective of a MIP
model, to give global directions how the ‘optimal’ hos-
pital infrastructure would be in the Dutch context. To
our knowledge, this is the first attempt to include the re-
cent literature regarding volume-outcome relationship
together with accessibility and efficiency characteristics
to model a new optimal hospital infrastructure from a
societal perspective.
Methods
Mathematical models are very suitable to make complex
trade-offs. Location models are studied for a long time
in science and industry. An excellent overview of the
various forms of location models can be found in Revelle
et al. and Melo et al.; they describe the use of location
models in supply chain management [19,20]. In our
study we use a mixed integer linear (MIP) programmingapproach in an AIMMS software environment with the
CPLEX solver to solve the Dutch hospital infrastructure
problem [21]. Objective, relations and constraints will be
explained in the following sections.
Models are very suitable, not only to find the optimal al-
location of infrastructure, but also to perform sensitivity
and ‘what-if ’ analysis. This should be kept in mind since this
is an explorative study in which estimations of the volume-
outcome relations based on expert opinions are used.
Conditions and hospital locations
To create the ‘ideal’ hospital landscape from the trade-
off between quality, accessibility and operational effi-
ciency, we first identified the possible hospital locations
in the Netherlands and conditions that should be allo-
cated. In the new hospital landscape, 150 possible hos-
pital locations were defined. This number was chosen
taken into account that: 1) There are enough locations
to provide health care close to home (the average travel
time currently with 95 hospital locations is 14.9 minutes
to the closest located hospital [22] 2) the number of pos-
sible locations would not become a serious constraint in
the model and 3) the model does not become too com-
plex. From the total of 150 locations, 88 of these loca-
tions are based on the 3-digit distinct zip code of the 95
current hospitals in the Netherlands. The other locations
are chosen in such a way that the total amount of 150
locations are optimally distributed in the Netherlands.
This means that the sum of the individual driving times
for all inhabitants is as small as possible. The density of
the population per zip code area was used to calculate
the optimal location of the hospitals [23].
Allocated diagnosis groups based on ICD-9-CM codes
The total health care delivered in hospitals in the
Netherlands was assigned to one of 30 diagnosis groups.
These diagnosis groups are slightly modified from the
diagnosis groups of the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM, WHO), in such a way that the groups are as homo-
geneous as possible with regard to:
 the volume-outcome relationship.
The diagnosis group ‘Signs, Symptoms, and Ill-defined
Conditions’, was excluded because of a lack of informa-
tion. The ICD-9-CM codes and corresponding 30 diag-
nosis groups are described in Table 1. We formulated
one obligatory relationship between ICD-9 groups in the
model: between gynecology and pediatric care (groups 21
and 23, see Table 1). In the current model, all other diag-
nosis groups can operate on their own or be combined
with other diagnosis groups if the efficiency constraint is
not met. Details of the criteria of the volume-outcome
Table 1 ICD-9 classification and diagnosis groups used in the present study
Main category ICD-9-CM classification The 30 diagnosis groups
Infectious and Parasitic Diseases 1 Acute infectious and parasitic diseases and poisoning
2 Chronic infectious and parasitic diseases (tuberculosis, HIV, hepatitis)
Neoplasms 3 Neoplasms
Endocrine, Nutritional, and Metabolic Diseases and Immunity Disorders 4 Diabetes
5 Endocrine, metabolic and immunity disorders
Diseases of Blood and Bloodforming Organs 6 Haematology
Mental Disorders 7 Acute mental disorders (i.e. psychosis)
8 Chronic mental disorders (i.e. rehabilitation programs, personality disorders)
Diseases of the Nervous System and Sense Organs 9 Diseases of the nervous system
10 Eyecare
11 Earcare
Diseases of the Circulatory System 12 Cerebral hemorrhage and ischemia
13 Chronic cardiovascular disease (including congestive heart failure)
14 Cardiovascular disease with intervention (PCI/CABG)
Diseases of the Respiratory System 15 Acute diseases of the respiratory system (i.e. pneumonia and influenza)
16 Complex pulmonary surgery
17 Common surgery of the respiratory system (i.e. tonsillitis)
18 Chronic obstructive pulmonary disease and allied conditions
Diseases of the Digestive System 19 Surgery of diseases of the digestive system
20 Diseases of oral cavity, salivary glands, and jaws
Diseases of the Genitourinary System 21 Gynaecology
22 Urinary system
Complications of Pregnancy, Childbirth, and the Puerperium 23 Complications of pregnancy, childbirth, and the puerperium
Diseases of the Skin and Subcutaneous Tissue 24 Dermatology
Diseases of the Musculoskeletal and Connective Tissue 25 Rheumatism and arthropathies (non surgical)
26 Diseases of the musculoskeletal system that require surgical treatment
Congenital Anomalies 27 Congenital disorders
Newborn (Perinatal) 28 Certain conditions originating in the perinatal period
Injury and Poisoning 29 Emergency care (distorsion, luxation, common fractures)
30 Specialized trauma care (injuries of organs, complex fractures)
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described in the paragraphs below.
Data: volume-outcome relationship
In this study we estimated per diagnosis group the
volume-outcome relationship compared to the diagnosis
group neoplasms. This diagnosis group was chosen as a
reference group, because the volume-outcome relation-
ship is well studied for the condition breast cancer in
the diagnosis group neoplasms and the angle of incli-
nation of outcomes expressed as Quality Adjusted Life-
time Years (QALY’s) per volume step has been established
in previous studies [22,24-31]. The study shows, in short,
that on average 0.5 QALY for an individual may be gained
per breast cancer treatment, when breast cancer care is
concentrated from the current 94 hospitals (that eachtreat 138 cases per year) to 15 specialized breast cancer
centers (that each treat 866 cases per year) centers. With
this concentration of care the current Dutch 5-year sur-
vival for breast cancer could improve from 85% to 90%
according to international literature and best practicesa
[22,24-32].
Although numerous studies have documented a
volume-outcome relationship, literature to quantify the
strength of this relationship is not available for all diag-
nosis groups. It is presumed that the association depends
on the level of complexity of the intervention and the
level of co-operation between different specialties [31,33].
Therefore based on the complexity of the diagnosis groups
we divided the diagnosis groups in four categories and
(somewhat arbitrarily) gauged volume-outcome relationship
in QALYs relative to the diagnosis group neoplasms: high
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mediate (50% of neoplasms), low (5% of neoplasms), or no
volume-outcome relationship.
The categories high, intermediate and low are established
using the following criteria:
 High: multi medical specialty treatment, low
volume, and high risk of complication, according to
previous reports e.g. [34] and current volume norms
per condition of professionals associations [35].
 Intermediate: a high complication risk but a single
medical specialty approach [34].
 Low: groups with a high volume and a low risk of
complication [34].
Since there is consensus in the literature that it is desir-
able that healthcare for chronic conditions is within close
reach, chronic care was not included in this classification.
As it requires frequent visits for relative low complex care,
often accompanied with lifestyle change, chronic care was
labeled as having no volume-outcome relationship [34].
After estimating the volume-outcome association per
diagnosis group we calculated the angle of inclination of
quality of care (expressed in QALYs) per diagnosis
group, by simulating a concentration of care per diagno-
sis group from the current 94 locations to a virtual sin-
gle centre (for the model formulation see below).
Data: accessibility
For acute diagnosis groups, the travel time is in the
Netherlands by law maximized on 45 minutes. Therefore we
also used this as the maximum travel time in the acute diag-
nosis groups [36]. The maximum travel time for other diag-
nosis groups were set at 120 minutes. This amount is
derived from Discrete Choice Experiments in which patients
state they are willing to travel up to 230 kilometers (approxi-
mately 2 hours by car) for better quality of care [37].
Data: use of resources
The average length of stay in the hospital is based on
the national medical registry [38]. For the average
lengths of stay in an Intensive Care Unit and the average
duration of an operation we used the KPMG Plexus
benchmark analysis of 70 hospitals in the Netherlands
[39]. Use of resources, such as length of stay in the hospital,
ICU admittance and use of operating rooms (OR). The
minimum utilizations were estimated using benchmarking
results from Dutch hospitals. For an OR the minimum
utilization was estimated as being 65% of the total time
available for operations (48 weeks a year, 5 days a week,
8 hours a day). For an ICU the minimum was estimated as
having 6 beds occupied during 365 days a year. For a
ward it was estimated as 80% utilization of 12 beds during
365 days a year.Data: costs per diagnosis group
The total costs per diagnosis group are estimated by the
National Institute for Public Health and the Environment
Cost of Illness in 2005 [40]. The abovementioned charac-
teristics per diagnosis group are summarized in Table 2.
The MIP model
The problem is formulated using a mixed integer linear
programming model, whereby accessibility and quality
are translated to euros. This will be further explained in
this section. We solve the instances by using the CPLEX
solver within the AIMMS development environment.
Objective function:
max ∑d Qualityd−Traveldð Þ
Constraints:
Qualityd ¼ EQNPd ad NLd þ bdð Þ for all d;
Traveld ¼ 2ET NVd∑
p;q
NPDp;d Y p;q;d TTp;q for all d;
Xp ¼ 1
∑
p
Y p;q;d ≤Zq;dM for all q; d;
∑
d
Zq;d ≤XqM for all q;
∑
q
Zq;d ¼ NLd for all d;
Yp;q;d TTp;q≤maxtd for all p; q; d;
∑
p;d
NPDp;d Y p;q;d Uf ;d ≥minuf Xp for all f ; p:
See below in Table 3 for the description of the indices,
parameters and decision variables.Model formulation
The objective of our model is the trade-off between
quality and accessibility of care (traveling time) in con-
centration and specialization of hospital care. This leads
to the following objective function:
max∑
d
Qualityd−Traveldð Þ
Quality: volume-outcome relationship
It is assumed that the volume-outcome relationships are
linear functions (ax + b) depending on the number of lo-
cations (NLd) treating a diagnosis group d (adNLd + bd).
After solving the problem the optimal number of loca-
tions is compared with the interval and if necessary an-
other interval (with another linear function) is chosena.
QALY’s are converted into monetary units (euros),
based on earlier described concepts, using € 50,000 per
QALY (EQ) which is a relative low number as previous
studies often use $100,000 per QALY [41]. To test the
robustness of our results we also ran the model using €
Table 2 The characteristics of the 30 diagnosis groups
Diagnosis groups Category Costs (mlj euro) Number of admissions Volume- outcome relation Maximum travel time (min)
Source: Poos et al. [40] LMR registry [38] expert opinion expert opinion
1 Acute infectious and parasitic diseases and poisoning Acute 95,8 93193 Intermediate 45
2 Chronic infectious and parasitic diseases Chronic 184,4 3885 High 120
3 Neoplasms Chronic 1845,1 405124 High 120
4 Diabetes Chronic 197,6 17445 Non existent 45
5 Endocrine, metabolic and immunity disorders Chronic 220 46837 Intermediate 45
6 Haematology Elective/Chr. 146,1 51064 High 45
7 Acute mental disorders Acute 85,7 12000 High 45
8 Chronic mental disorders Chronic 306,6 22134 Non existent 45
9 Diseases of the nervous system Chronic 522,2 89335 Low 45
10 Eyecare Elective 596,9 207327 Low 45
11 Earcare Elective 230,4 61090 Intermediate 45
12 Cerebral hemorrhage/ischemia Acute 436,3 47925 High 45
13 Chronic cardiovascular disease (including congestive heart failure) Chronic 938,5 180186 Non existent 45
14 Cardiovascular disease with intervention (PCI/CABG) Acute 1047,7 163275 High 45
15 Acute diseases of the respiratory system Acute 246,7 64310 Low 45
16 Complex pulmonary surgery Elective 305,6 20502 High 45
17 Common surgery of the respiratory system Elective 122,1 74168 Low 45
18 Chronic obstructive pulmonary disease and allied conditions Chronic 305,5 48236 Non existent 120
19 Surgery of diseases of the digestive system Elective 422,7 215757 Intermediate 45
20 Diseases of oral cavity, salivary glands, and jaws Chronic 1108,9 26366 Low 45
21 Gynaecology Elective 481,6 82053 Low 45
22 Urinary system Elective 497,1 151334 Low 45
23 Complications of pregnancy, childbirth and the puerperium Elective 739,3 296513 Intermediate 45
24 Dermatology Chronic 412,3 68625 Low 45
25 Rheumatism and arthropathies (non surgical) Chronic 961,2 157265 Low 45
26 Diseases of the musculoskeletal system that require surgical treatment Elective 857,3 238155 Intermediate 45
27 Congenital disorders Chronic 216,1 25669 High 120
28 Conditions originating in the perinatal period Elective 331,2 75980 High 120
29 Signs, symptoms and ill-defined conditions - 2.746,30 346106 Intermediate 45
30 Emergency care Acute 604,1 52605 Non existent 45
31 Specialized trauma care Acute 475,6 77330 High 120
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Table 3 Description of indices, parameters & variables
Notation Description
Indices
d Diagnosis group
f Facility
p Zip code area
q Zip code area
Parameters
ad The slope of the (linear) volume-outcome
relationship of diagnosis group d
bd The constant term of the (linear) volume-outcome
relationship of diagnosis group d
EQ Euros per QALY
ET Travel expenses per time unit
M Big number [1,000,000]
maxtd The maximum acceptable travel time
for diagnosis group d
minuf Minimum utilization per facility f
NPd The number of patients per diagnosis group d
NPDp;d The number of patients per diagnosis
group d and zip code p
NVd The total number of visits per patient
having diagnosis d
TTp,q The driving time from zip code p to zip code q
Ufd The amount of resources each patient within
diagnosis group d makes use of facility f
Dependent variables
Qualityd Total quality achieved for diagnosis group d [euros]
Traveld Total travel costs made for diagnosis group d [euros]
NLd The number of locations treating diagnosis group d
Decision variables
Xp Whether a health care location is
established in zip code p
Zq,d Whether diagnosis group d is treated at
potential hospital location with zip code q
Yp,q,d Whether for diagnosis group d patients
from zip code p are assigned to potential
hospital location with zip code q
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this is also a sensitivity analysis for the assumptions we
made for the volume-outcome relationship.
The volume-outcome relationship for a disease group
d is now as follows:
Qualityd ¼ EQNPd ad NLd þ bdð Þ for all d;
Accessibility
The second element in the objective is travel time. The
travel time of patients is calculated based on the demo-
graphics per zip code [23], using similar approaches asprevious studies measuring accessibility of care [42]. The
Netherlands are divided in 794 zip code areas (the Dutch
Frisian Islands are excluded). The percentage wise distri-
bution of patients for every diagnosis group is assumed
identical for these 794 zip code areas.
Total travel expenses per diagnosis group are based on
the number of patients (NPDp,d per diagnosis group d and
zip code p), the total amount of time traveling (number
of visits times travel time) and the travel expenses per
time unit (ET).
The total number of visits per patient having diagnosis
d (NVd) was taken from current guidelines in which the
number of outpatient clinic visits (including possible radio-
therapy/chemotherapy and follow-up visits). It is assumed
that all treatments take place at one location, including
follow-up visits. For the driving time to the hospital loca-
tions (TTp,q) the Dutch Drive Time Matrix was used [43].
The travel expenses per hour (ET) are derived from
the costs of traveling by taxi (€2.20 per kilometer) [44]
and the loss of income by traveling, using the national
median income of €32,000 a year for 1,600 working
hours [23]. We assumed that apart from the patient, a
second person always accompanies the patient. Based on
the literature regarding patient preferences – as men-
tioned in the introduction – we assumed that all patients
are willing to travel as these travel costs are compensated
by a higher quality of care. As we know that individual pa-
tient preferences regarding willingness to travel may differ,
this is a limitation of our used data and approach.
For all diagnosis groups d a maximum is set – based
on expert opinions – on the acceptable travel time
(maxtd) for patients. The decision variable Yp,q,d, which
assigns zip code areas to potential hospitals for a diagno-
sis group, is restricted to the domain (p,q,d) with:
Yp;q;d TTp;q≤maxtd for all p; q; d:
The costs for traveling for a diagnosis group d is as
follows:
Traveld ¼ 2ET NVd∑
p;q
NPDp;d Y p;q;d TTp;q for all d:
Constraint: efficient use of resources
Efficiency is regarded as operational efficiency concerning
three facilities f:
 Operating room (OR)
 Ward
 Intensive care unit (ICU)
It is assumed that there are no capacity limitations for
these facilities and that the same facility can be used for
different diagnosis groups.
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minimum utilization (minuf) is reached. How much a fa-
cility is used depends on the number of patients coming to
this specific healthcare location p (∑p;dNPDp;dY p;q;d where
NPDp,d is the number of patients with diagnosis d living in
zipcode q and Yp,q,d indicates to which healthcare location
p these patients go for care) and how much each patient
makes use of this facility (Uf,d).
This leads to the following constraint:
∑
p;d
NPDp;d Y p;q;d Uf ;d ≥minuf Xp for all f ; p:
No ethical approval was required for this study.
Results
The above model has been run with the data as discussed.
Figure 1 shows per diagnosis group the number of loca-
tions that ideally provides care for patients with a disease
from that diagnosis group. The number of locations vary
from 12 locations for diagnosis groups like congenital
anomalies and 14 locations for neoplasms, which have aFigure 1 Number of locations per diagnosis group, including sensitiv
groups the number of location did not alter with adjusting the monetary v
cases only the thick horizontal lines is displayed.high volume-outcome relationship, to 150 locations for
chronic diagnosis groups such as diabetes and chronic ob-
structive pulmonary disease (COPD). Also the figure dis-
plays the results from the model using € 20.000 per QALY
and € 100.000 per QALY.
In the new hospital landscape, care for acute diagnosis
groups and diagnosis groups with a strong volume-
outcome relationship is provided on less locations than
in the current situation. Patients with a chronic disease
have less travel time than they have nowadays. Figure 2
shows the travel time for patients with acute, chronic or
other diseases in the new hospital landscape. In the
current landscape of 94 hospitals the average travel time
is 14.9 minutes, whereas, given the number of locations
per diagnosis group in Figure 1 with the scenario of €
50.000 per QALY the travel time will be 28.9 minutes.
Discussion
In this study we explored how the optimal hospital land-
scape may look like based on a MIP model that tradeoffs
the dimensions efficiency, quality and accessibility of
hospital care in the Dutch context.ity analyses with different values per QALY1. 1For some diagnosis
alue per QALY to €P 20.000 and €100.000 (such as earcare). In such
Figure 2 Travel time by car to nearest hospital per type of
diagnosis group.
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gest that the current Dutch hospital landscape is too dis-
persed and too concentrated at the same time. For the
more complex diagnosis groups such as neoplasms, pa-
tients would benefit from more concentration of care,
where for chronic diagnosis groups such as COPD and
diabetes optimal value may be created by making care
more accessible to patients by providing chronic care at
more locations throughout the country. These findings
are in line with previous non empirical but rather con-
ceptual studies regarding the Dutch hospital landscape
that also advocates more dispersion for chronic care and
more concentration for acute and/or complex diagnosis
groups [45].
Based on our findings we believe that other countries
or regions can apply our model as well.
Moreover we see that this development of concentra-
tion of care is actually happening in the Dutch hospital
market; associations of medical specialists are formulat-
ing minimum volume norms for a range of conditions,
resulting in fewer hospitals providing treatments for
complex care [46]. In addition, there is a trend of mer-
ging of (smaller) hospitals, probably caused by efficiency
pressures, concentration of care to enhance quality as
well as market power considerations [37]. This latter de-
velopment is not necessarily in line with the findings of
our model as hospitals tend to merge as a whole, making
no differentiation between characteristics of individual
(groups of ) diagnosis.
The main contribution of this study compared to pre-
vious hospital allocation studies is that it systemically in-
cludes the quality of care dimension [16-18]. Just these
dimension is very highly rated by patients in multiple
studies, that show that patients are willing to travel substan-
tial distances for higher quality of care [11,47,48]. There-
fore, including the quality of care dimensions in hospitalallocation models that are used by policy makers, may im-
prove the alignment of the hospital infrastructure with the
preferences of society as a whole and individual patients.
It is important to state that this study has an explora-
tive character especially because the volume-outcome
relationship is not established yet for all different diag-
nosis groups let alone all the individual diagnosis. Future
research regarding the volume-outcome relationship
may alter the used input data and thereby alter the opti-
mal number of locations per diagnosis group. In addition
we did not include specialization effects of hospitals in
our model and only ensured a minimal scale of hospitals
but did not fully model economies of scale nor econ-
omies of scope effects. Also we did not include potential
price effects due to a potentially lower level of competi-
tion between providers. However, most of these effects,
like other constraints or functions, could be added to
this approach as well: nearly the only aspect that needs
to be taken into account is the size of the mathematical
model (otherwise it cannot be solved within a reasonable
time frame). Last, it is important to state that our model
does not include individual preferences of patients, this
implies that our findings of a different hospital landscape
do not necessarily match with (all) individual preferences.Conclusion
In conclusion, our study shows a new approach for de-
termining the allocation of diagnosis groups in a hospital
blueprint in a country or certain region. This approach,
considering quality of care in relation to volume per pro-
vider, can be used in various countries or regions. In
addition, our model shows that within the Dutch context
chronic care may be too concentrated while complex
and acute care may be too dispersed.Endnotes
a To calculate the gain in QALYs, three figures were
used, information from national statistics and literature 1)
A patient who survives 10 years after the diagnosis lives
on for another 10 years on average. This is based on the
average age of diagnosis in the Netherlands (60 years),
and the average life expectancy at age 60 (about 23 years)
The quality of life of breast cancer patients is between 80-
90% when surviving 5 to 10 years, and 50% at most when
dying within 5 to 10 years 3) The quality of life is equal
for all patients that survived the diagnosis, regardless
whether they are treated in high-volume or low-volume
hospitals.
b More accurate would be to regard the relationship as
a continuous convex function. For modeling purposes a
linear function is chosen that approaches the convex
function in the interval of the expected number of opti-
mal locations.
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